Boston Scientific Corp
BSX106.650USD
+0.609+0.58%
종가 05/19, 16:00（ET）시세는 15분 지연됩니다
157.76B시가총액
85.14P/E TTM
자세한 내용은 Boston Scientific Corp 회사
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
회사 정보
회사 코드BSX
회사 이름Boston Scientific Corp
상장일May 19, 1992
설립일1979
CEOMr. Michael F. (Mike) Mahoney
직원 수53000
유형Ordinary Share
회계 연도 종료May 19
주소300 Boston Scientific Way
도시MARLBOROUGH
증권 거래소NYSE Consolidated
국가United States of America
우편 번호01752-1234
전화15086834000
웹사이트https://www.bostonscientific.com/en-US/Home.html
회사 코드BSX
상장일May 19, 1992
설립일1979
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.81M
-3.15%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
36.19K
-11.77%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
4.98K
+71.73%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ms. Meghan Scanlon
Ms. Meghan Scanlon
Senior Vice President and President - Urology
Senior Vice President and President - Urology
--
--
Mr. David Scott (Dave) Wichmann
Mr. David Scott (Dave) Wichmann
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.81M
-3.15%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
36.19K
-11.77%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
4.98K
+71.73%
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
지역별USD
이름
수익
비율
United States
10.21B
60.97%
EMEA (Europe, Middle East and Africa)
3.23B
19.28%
Asia Pacific
2.69B
16.04%
Latin America and Canada
624.00M
3.73%
사업별
지역별
사업별USD
이름
수익
비율
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
주주
업데이트 시간: Wed, May 14
업데이트 시간: Wed, May 14
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
주주 통계
주주
비율
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
유형
주주
비율
Investment Advisor
43.48%
Investment Advisor/Hedge Fund
36.88%
Hedge Fund
3.84%
Pension Fund
2.86%
Research Firm
2.46%
Bank and Trust
1.70%
Sovereign Wealth Fund
1.54%
Private Equity
0.20%
Insurance Company
0.19%
Other
6.84%
기관 주식 보유
업데이트 시간: Sun, Jan 19
업데이트 시간: Sun, Jan 19
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
2650
1.38B
93.37%
-1.15M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
2022Q4
1993
1.36B
94.66%
-54.91M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
132.25M
8.94%
+1.62M
+1.24%
Dec 31, 2024
Fidelity Management & Research Company LLC
121.20M
8.19%
-2.05M
-1.66%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
76.72M
5.19%
+7.50M
+10.84%
Dec 31, 2024
State Street Global Advisors (US)
63.96M
4.32%
+1.12M
+1.78%
Dec 31, 2024
PRIMECAP Management Company
36.93M
2.5%
-896.83K
-2.37%
Dec 31, 2024
Wellington Management Company, LLP
36.17M
2.45%
+3.34M
+10.19%
Dec 31, 2024
Geode Capital Management, L.L.C.
30.63M
2.07%
+1.04M
+3.52%
Dec 31, 2024
Capital World Investors
27.90M
1.89%
+6.22M
+28.67%
Dec 31, 2024
Managed Account Advisors LLC
17.69M
1.2%
+122.78K
+0.70%
Dec 31, 2024
The Bollard Group, LLC
20.73M
1.4%
-510.32K
-2.40%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
iShares U.S. Medical Devices ETF
10.77%
Goldman Sachs Future Health Care Equity ETF
8.32%
NYLI Healthy Hearts ETF
4.83%
Horizon Expedition Plus ETF
4.24%
iShares US Thematic Rotation Active ETF
4%
Global X Aging Population ETF
3.98%
iShares Health Innovation Active ETF
3.83%
Hennessy Stance ESG ETF
3.48%
iShares Large Cap Active ETF
3.2%
JPMorgan Healthcare Leaders ETF
3.1%
더 보기
iShares U.S. Medical Devices ETF
비율10.77%
Goldman Sachs Future Health Care Equity ETF
비율8.32%
NYLI Healthy Hearts ETF
비율4.83%
Horizon Expedition Plus ETF
비율4.24%
iShares US Thematic Rotation Active ETF
비율4%
Global X Aging Population ETF
비율3.98%
iShares Health Innovation Active ETF
비율3.83%
Hennessy Stance ESG ETF
비율3.48%
iShares Large Cap Active ETF
비율3.2%
JPMorgan Healthcare Leaders ETF
비율3.1%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
